A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation

In January 2003, a 55-year old, non-smoking woman visited our hospital to undergo treatment for T4N0M0 pulmonary adenocarcinoma of the left lung. Until death in October 2015, she received over 20 lines of treatment including a second line therapy with gefitinib, which showed long response. In March...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Fumio, Inoue, Takako, Kimura, Madoka, Nishino, Kazumi, Kumagai, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053035/
https://www.ncbi.nlm.nih.gov/pubmed/27747151
http://dx.doi.org/10.1016/j.rmcr.2016.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053035/
https://www.ncbi.nlm.nih.gov/pubmed/27747151
http://dx.doi.org/10.1016/j.rmcr.2016.09.002

Ejemplares similares